Impact of Antimicrobial Agents on Human Intestinal Microflora

References

• Nord CE, Heimdahl A, Kager L, Malmborg AS. The impact of different antimicrobial agents on the normal gastrointestinal microflora of humans. Rev Infect Dis 1984; 6: S270–5.
   Google Scholar
• Heimdahl A, Nord CE. Effect of phenoxymethyl-penicillin and clindamycin on the oral, throat and faecal microflora on man. Scand J Infect Dis, 1979; 11: 233–42.
   Google Scholar
• Knothe H, Wiedemann B. Die Wirkung von Ampicillin auf die Darmflora des gesunden Menschen. Zentralbl Bakteriol Hyg I Abt, 1965; A 197: 234–43.
   Google Scholar
• Leigh DA. Pharmacology and toxicological studies with amoxycillin, talampicillin and ampicillin and a clinical trial of parenteral amoxycillin in serious hospital infections. Drugs Exptl Clin Res, 1979; 5: 129–39.
   Google Scholar
• Gipponi M, Sciutto C, Accornero L, Bonassi S, Raso C, Vignolo C, Cafiero F. Assessing modifications of the intestinal bacterial flora in patients on long-term oral treatment with bacampicillin or amoxycillin: A random study. Chemioterapia, 1985; 4: 214–7.
   Google Scholar
• Heimdahl A, Nord CE, Weilander K. Effect of bacampicillin on human mouth, throat and colon flora. Infection, 1979; 7: S446–51.
   Google Scholar
• Knothe H, Lembke L). The effect of ampicillin and pivampicillin on the intestinal microflora of man. Zntralbl Bakteriol Hyg I Abt, 1973; A223: 324–32.
   Google Scholar
• Leigh DA, Reeves DS, Simmons K, Thomas AL, Wilkonson PJ. Talampicillin: A new derivate of ampicillin. Br Med J, 1976; 1: 1378–80.
   Google Scholar
• Knothe H. The effect of pivmecillinam on the human gut flora. Arzneimittel forschung (Drug Reg.), 1976; 26: 427–30.
   Google Scholar
• Kager L, Malmborg AS, Nord CE, Sjöstedt S. The effect of piperacillin prophylaxis on the colonic microflora in patients undergoing colorectal surgery. Infection, 1983; 11: 251–4.
   Google Scholar
• Nord CE, Bergan T, Aase S. Impact of azlocillin on the colon microflora. Scand J Infect Dis, 1986; 18: 163–6.
   Google Scholar
• Van Der Waaij D. Selective decontamination of the digestive tract with oral aztreonam and temocillin. Rev Infect Dis, 1985; 7: S628–34.
   Google Scholar
• Nord CE, Bergan T, Thorsteinsson SB. Impact of ticarcillin/clavulanate on the intestinal microflora. J Antimicrob Chemother, 1989; 24: Suppl B, 221–6.
   Google Scholar
• Ambrose NS, Johnson M, Burdon BW, Keighley MR. The influence of single dose intravenous antibiotics on faecal flora and emergence of Clostridium difficile. J Antimicrob Chemother, 1985; 15: 319–26.
   Google Scholar
• Vogel F, Knothe H. Changes in aerobic faecal flora of severely ill patients during antibiotic treatment. Klin Wochenschr, 1985; 63: 1174–9.
   Google Scholar
• Finegold SM, Ingram-Drake L, Gee R, Reinhardt J, Edelstein MAC, MacDonald K, Wexler H. Bowel flora changes in humans receiving cefixime (CL 248, 635) or cefaclor. Antimicrob Agents Chemother, 1987; 31: 443–6.
   Google Scholar
• Nord CE, Heimdahl A, Lundberg C, Marklund G. Impact of cefaclor on the normal human oropharyngeal and intestinal microflora. Scand J Infect Dis, 1987; 19: 681–5.
   Google Scholar
• Lode H, Müller C, Borner K, Nord CE, Koeppe P. Cephrocile: Multiple-dose pharmacokinetics and impact on the intestinal flora in volunteers. Antimicrob Agents Chemother, in press, 1990.
   Google Scholar
• Kager L, Brismar B, Malmborg AS, Nord CE: Impact of cefbuperazone on the colonic microflora in patients undergoing colorectal surgery. Drugs Exptl Clin Res, 1986; 12: 983–6.
   Google Scholar
• Kager L, Ljungdahl I, Malmborg AS, Nord CE, Pieper R, Dahlgren P. Antibiotic prophylaxis with cefoxitin in colorectal surgery. Ann Surg, 1981; 193: 277–82.
   Google Scholar
• Mulligan ME, Citron D, Gabay E, Kirby BD, George WL, Finegold SM. Alterations in human fecal flora including ingrowth of Clostridium difficile related to cefoxitin therapy. Antimicrob Agents Chemother, 1984; 26: 343–6.
   Google Scholar
• Knothe H, Dette GA, Shah PM. Impact of injectable cephalosporins on the gastrointestinal microflora. Observations in healthy volunteers and hospitalized patients. Infection, 1985; 13: S129–33.
   Google Scholar
• Nord CE, Movin G, Stålberg D. Impact of cefixime on the normal intestinal microflora. Scand J Infect Dis, 1988; 20: 547–52.
   Google Scholar
• Lambert-Zechovsky N, Bingen E, Aujard Y, Mathieu H. Impact of cefotaxime on the fecal flora in children. Infection 1985; 13: S140–4.
   Google Scholar
• Guggenbichler JP, Kofler J. Influence of third generation cephalosporins on aerobic intestinal microflora. J Antimicrob Chemother, 1984; 14: 67–70.
   Google Scholar
• Kager L, Malmborg AS, Nord CE, Sjöstedt S. Impact of single dose as compared to three dose prophylaxis with moxalactam on the colonic microflora in patients undergoing colorectal surgery. J Antimicrob Chemother, 1984; 14: 171–7.
   Google Scholar
• Alestig K, Carlberg H, Nord CE, Trollfors B. Effect of cefoperazone on faecal flora. J Antimicrob Chemother, 1983; 12: 163–7.
   Google Scholar
• Lambert-Zechovsky N, Bingen E, Proux MC, Aujard Y, Mathieu H. Effects of cefoperazone on children's fecal flora. Pathol Biol, 1984; 32: 439–42.
   Google Scholar
• Arvidsson A, Alvan G, Angelin B, Borgå B, Nord CE. Ceftriaxone: Renal and biliary excretion and effect on the colon microflora. J Antimicrob Chemother, 1982; 10: 207–15.
   Google Scholar
• Nilsson-Ehle I, Nord CE, Ursing B. Ceftriaxone: Pharmacokinetics and effect on the intestinal microflora in patients with acute bacterial infections. Scand J Infect Dis, 1985; 17: 77–82.
   Google Scholar
• Kager L, Brismar B, Malmborg AS, Nord CE. Effect of aztreonam on the colon microflora in patients undergoing colorectal surgery. Infection, 1985; 13: 111–14.
   Google Scholar
• De Vries-Hospers HG, Welling GW, Swabb EA, Van Der Waaij D. Selective decontamination of the digestive tract with aztreonam. A study of 10 healthy volunteers. J Infect Dis, 1984; 150: 636–42.
   Google Scholar
• Jones PG, Bodey GP, Swabb EA, Rosenbaum B: Effect of aztreonam on throat and stool flora of cancer patients. Antimicrob Agents Chemother 1984; 26: 941–43.
   Google Scholar
• Nord CE, Kager L, Philipson A, Stiernstedt G. Impact of imipenem/cilastatin therapy on faecal flora. Eur J Clin Microbiol, 1984; 3: 475–7.
   Google Scholar
• Kager L, Brismar B, Malmborg AS, Nord CE. Imipenem concentrations in colorectal sugery and impact on the colonic microflora. Antimicrob Agents Chemother 1989; 33: 204–8.
   Google Scholar
• Mittermayer HW. The effect of amoxycillin and amoxycillin plus clavulanic acid on human bowel flora. In: Augmentin: Clavulanate-potentiated Amoxycillin. (E.A.P. Croydon, M.F. Michel eds.), 1983: 125–133.
   Google Scholar
• Lambert-Zechovsky N, Bingen E, Proux MC, Aujard Y, Mathieu H: Effect of amoxycillin combined with clavulanic acid on the fecal flora of children. Pathol Biol, 1984; 32: 436–42.
   Google Scholar
• Wise R, Bennet SA, Dent J: The pharmacokinetics of orally absorbed cefuroxime compared with amoxycillin/clavulanic acid. J Antimicrob Chemother, 1984; 13: 603–10.
   Google Scholar
• Motohiro T, Tanaka K, Koga T et al. Effect of BRL 25000 (Clavulanic-amoxycillin) on bacterial flora in human feces. Jpn J Antibiot, 1985; 38: 441–50.
   Google Scholar
• Brumfitt W, Franklin I, Grady D, Hamilton JMT. Effect of amoxicillin-clavulanate and cephradine on the fecal flora of healthy volunteers not exposed to a hospital environment. Antimicrob Agents Chemother, 1986; 30: 335–7.
   Google Scholar
• Kager L, Liljeqvist L, Malmborg AS, Nord CE, Pieper R. Effects of ampicillin plus sulbactam on bowel flora in patients undergoing colorectal surgery. Antimicrob Agents Chemother, 1982; 22: 208–12.
   Google Scholar
• Kager L, Malmborg AS, Sjöstedt S, Nord CE. Concentrations of ampicillin plus sulbactam in serum and intestinal mucosa and effects on the colonic microflora in patients undergoing colorectal surgery. Eur J Clin Microbiol, 1983; 2: 559–63.
   Google Scholar
• Heimdahl A, Nord CE. Effect of erythromycin and clindamycin on the indigenous human anaerobic flora and new colonization of the gastrointestinal tract. Eur J Clin Microbiol, 1982; 1: 34–48.
   Google Scholar
• Bartlett JB, Bustetter LA, Gorbach SL, Onderdonk AB. Comparative effect of tetracycline and doxycycline on the occurrence of resistant Escherichia coli in the fecal flora. Antimicrob Agents Chemother, 1975; 7: 55–7.
   Google Scholar
• Heimdahl A, Nord CE. Influence of doxycycline on the normal human flora and colonization of the oral cavity and colon. Scand J Infect Dis, 1983; 15: 293–302.
   Google Scholar
• Heimdahl A, Nord CE, Okuda K. Effect of tinidazole on the oral throat and colon microflora of man. Med Microbiol Immunol, 1980; 168: 1–10.
   Google Scholar
• Kager L, Ljungdahl I, Malmborg AS, Nord CE. Effect of tinidazole prophylaxis on the normal microflora in patients undergoing colorectal surgery. Scand J Infect Dis, 1981; 26: 84–91.
   Google Scholar
• Eriksson G, Nord CE. Impact of topical metronidazole on the skin and colon microflora in patients with rosacea. Infection 1987; 15: 8–10.
   Google Scholar
• Nord CE. Ecological impact of narrow spectrum anti-microbial agents compared to broad spectrum agents on the intestinal human microflora. Microecology and Therapy, in press, 1990.
   Google Scholar
• Kager L, Liljeqvist L, Malmborg AS, Nord CE. Effect of clindamycin prophylaxis on the colonic microflora in patients undergoing colorectal surgery. Antimicrob Agents Chemother, 1981; 20: 736–40.
   Google Scholar
• Nordenvall B, Hallberg D, Larsson L, Nord CE. The effect of clindamycin on the intestinal flora in patients with enteric hyperoxaluria. Scand J Gastroenterol, 1983; 18: 177–81.
   Google Scholar
• Brumfitt W, Franklin I, Grady D, Hamilton-Miller JMT, Iliffe A: Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers. Antimicrob Agents Chemother, 1984; 26: 757–61.
   Google Scholar
• Rozenberg-Arska M, Dekker AW, Verhoef J: Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: The effect on fecal flora. J Infect Dis, 1985; 152: 104–7.
   Google Scholar
• Enzenberger R, Shah PM, Knothe H. Impact of oral ciprofloxacin on the faecal flora of healthy volunteers. Infection, 1985; 13: 273–5.
   Google Scholar
• Bergan T, Delin C, Johansen S, Kolstad IM, Nord CE, Thorsteinsson SB. Pharmacokinetics of ciprofloxacin and effect of repeated dosage on salivary faecal microflora. Antimicrob Agents Chemother, 1986; 29: 298–302.
   Google Scholar
• Van Saene JJM, Van Saene HKF, Geitz JN, Tarko-Smit NJPh, Lerk CF. Quinolones and colonization resistance in human volunteers. Pharm Weekbl (Sci), 1986; 8: 67–71.
   Google Scholar
• Holt HA, Lewis DA, White LO, Bastable SY, Reeves DS: Effect of oral ciprofloxacin on the faecal flora of healthy volunteers. Eur J Clin Microbiol, 1986; 5: 201–5.
   Google Scholar
• Esposito S, Barba D, Galante D, Gaeta GB, Laghezza O. Intestinal microflora changes induced by ciprofloxacin and treatment of portal-systematic encephalopathy. Drugs Exptl Clin Res, 1987; 10: 641–6.
   Google Scholar
• Ljungberg B, Nilsson-Ehle I, Edlund C, Nord CE: Influence of ciprofloxacin on the colonic microflora in young and elderly volunteers: No impact of the altered drug absorption. Scand J Infect Dis, in press, 1990.
   Google Scholar
• Brismar B, Edlund C, Malmborg AS, Nord CE. Ciprofloxacin concentrations and impact of the colon microflora in patients undergoing colorectal surgery. Antimicrob Agents Chemother, 1990; 34: 481–3.
   Google Scholar
• Edlund C, Lidbeck A, Kager L, Nord CE. Effect of enoxacin on colonic microflora of healthy volunteers. Eur J Clin Microbiol, 1987; 6: 298–300.
   Google Scholar
• Meckenstock R, Haralambie E, Linzenmeier G, Wendt F: Die Beeinflussung der Darmflora durch Norfloxacin bei gesunden Menschen. Z Antimikr Antineoplast Chemother, 1985; 1: 27–34.
   Google Scholar
• De Vries-Hospers HG, Welling GW, Swabb EA, Van Der Waaij D. Norfloxacin for selective decontamination. A study in human volunteers. Progr Clin Biol Res 1985; 181: 259–62.
   Google Scholar
• Leigh DA, Emmanuel FXS, Tighe C, Hancock P, Boddy S. Pharmacokinetic studies of norfloxacin in healthy volunteers and effect on the faecal flora. Proc Int Cong Chemother. 14th, Kyoto 1985: 1835–1836.
   Google Scholar
• Pecquet S, Andremont A, Tancrède C: Selective anti-microbial modulation of the intestinal tract by norfloxacin in human volunteers and in gnotobiotic mice associated with human faecal flora. Antimicrob Agents Chemother, 1986; 29: 1047–52.
   Google Scholar
• Edlund C, Bergan T, Josefsson K, Solberg R, Nord CE. Effect of norfloxacin on human oropharyngeal and colonic microflora and multiple-dose pharmacokinetics. Scand J Infect Dis, 1987; 19: 113–21.
   Google Scholar
• Pecquet S, Andremont A, Tancrède C. Effect of ofloxacin on fecal bacteria in human volunteers. Antimicrob Agents Chemother 1987; 31: 124–5.
   Google Scholar
• Chida T, Shibaoka H, Ishizuka I, Nakaya R. The effect of ofloxacin (DL8280), a new antibacterial agent of pyridonecarboxylic acid derivative, on human fecal flora. Chemotherapy, 1984; 32: 109–17.
   Google Scholar
• Edlund C, Kager L, Malmborg AS, Sjöstedt S, Nord CE. Effect of ofloxacin on oral and gastrointestinal microflora in patients undergoing colorectal surgery. Eur J Clin Microbiol Infect Dis 1988; 7: 135–43.
   Google Scholar
• Edlund C, Brismar B, Nord CE. Effect of lomefloxacin on the normal oral and intestinal microflora. Eur J Clin Microbiol Infect Dis, 1990; 9: 35–9.
   Google Scholar